Stable mometasone furoate cream and preparation method thereof

The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YUAN LIXING, CHENG LU, DAI XIAOHUA, ZHU KEXU, WANG HAO, LIU XIAOQIONG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YUAN LIXING
CHENG LU
DAI XIAOHUA
ZHU KEXU
WANG HAO
LIU XIAOQIONG
description The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116421549A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116421549A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116421549A3</originalsourceid><addsrcrecordid>eNrjZLALLklMyklVyM3PTS1JLM7PS1VIKy3KTyxJVUguSk3MVUjMS1EoKEotSCxKLMnMz1MAKsvIT1EoyUgtSs1P42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoZmJkaGpiaWjsbEqAEAfT4w3g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Stable mometasone furoate cream and preparation method thereof</title><source>esp@cenet</source><creator>YUAN LIXING ; CHENG LU ; DAI XIAOHUA ; ZHU KEXU ; WANG HAO ; LIU XIAOQIONG</creator><creatorcontrib>YUAN LIXING ; CHENG LU ; DAI XIAOHUA ; ZHU KEXU ; WANG HAO ; LIU XIAOQIONG</creatorcontrib><description>The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230714&amp;DB=EPODOC&amp;CC=CN&amp;NR=116421549A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230714&amp;DB=EPODOC&amp;CC=CN&amp;NR=116421549A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YUAN LIXING</creatorcontrib><creatorcontrib>CHENG LU</creatorcontrib><creatorcontrib>DAI XIAOHUA</creatorcontrib><creatorcontrib>ZHU KEXU</creatorcontrib><creatorcontrib>WANG HAO</creatorcontrib><creatorcontrib>LIU XIAOQIONG</creatorcontrib><title>Stable mometasone furoate cream and preparation method thereof</title><description>The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLALLklMyklVyM3PTS1JLM7PS1VIKy3KTyxJVUguSk3MVUjMS1EoKEotSCxKLMnMz1MAKsvIT1EoyUgtSs1P42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoZmJkaGpiaWjsbEqAEAfT4w3g</recordid><startdate>20230714</startdate><enddate>20230714</enddate><creator>YUAN LIXING</creator><creator>CHENG LU</creator><creator>DAI XIAOHUA</creator><creator>ZHU KEXU</creator><creator>WANG HAO</creator><creator>LIU XIAOQIONG</creator><scope>EVB</scope></search><sort><creationdate>20230714</creationdate><title>Stable mometasone furoate cream and preparation method thereof</title><author>YUAN LIXING ; CHENG LU ; DAI XIAOHUA ; ZHU KEXU ; WANG HAO ; LIU XIAOQIONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116421549A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YUAN LIXING</creatorcontrib><creatorcontrib>CHENG LU</creatorcontrib><creatorcontrib>DAI XIAOHUA</creatorcontrib><creatorcontrib>ZHU KEXU</creatorcontrib><creatorcontrib>WANG HAO</creatorcontrib><creatorcontrib>LIU XIAOQIONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YUAN LIXING</au><au>CHENG LU</au><au>DAI XIAOHUA</au><au>ZHU KEXU</au><au>WANG HAO</au><au>LIU XIAOQIONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Stable mometasone furoate cream and preparation method thereof</title><date>2023-07-14</date><risdate>2023</risdate><abstract>The mometasone furoate cream provided by the invention only contains one emulsifier, the stability of the mometasone furoate cream can be remarkably improved, degradation of active ingredients and increase of impurity content can be reduced by virtue of the specific emulsifier hydrogenated soybean lecithin or mutual cooperation of soybean lecithin and a stabilizer edetate disodium, and the obtained cream is stable in performance, free of toxic and side effects and free of side effects. And the mometasone furoate cream is controllable in quality. Tests show that the mometasone furoate cream provided by the invention has stability superior to that of a commercially available product, namely, allocone, and can keep stable characters under the conditions of high temperature, high humidity, low temperature, freeze thawing and illumination, and maximum single impurities and total impurities in the product are not obviously increased. Meanwhile, the mometasone furoate cream disclosed by the invention is simple in pr</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116421549A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Stable mometasone furoate cream and preparation method thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T20%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YUAN%20LIXING&rft.date=2023-07-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116421549A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true